Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo‐Controlled Phase III Study-Reference-Cited by-同舟云学术

Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo‐Controlled Phase III Study

Published:2020-11-24 Issue:1 Volume:73 Page:110-120
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Deodhar Atul¹^ORCID,Blanco Ricardo²,Dokoupilová Eva³,Hall Stephen⁴,Kameda Hideto⁵^ORCID,Kivitz Alan J.⁶,Poddubnyy Denis⁷^ORCID,Sande Marleen⁸,Wiksten Anna S.⁹,Porter Brian O.¹⁰,Richards Hanno B.⁹,Haemmerle Sibylle⁹,Braun Jürgen¹¹

Affiliation:

1. Oregon Health & Science University Portland

2. Hospital University Marqués de Valdecilla IDIVAL Santander Spain

3. Medical Plus, s.r.o., Uherské Hradiště, Czech Republic University of Veterinary and Pharmaceutical Sciences Brno Czech Republic

4. Monash University Melbourne Victoria Australia

5. Toho University Tokyo Japan

6. Altoona Center for Clinical Research Duncansville Pennsylvania

7. Charité Universitätsmedizin Berlin Germany

8. Amsterdam UMC University of Amsterdam Amsterdam Rheumatology and Immunology Center Amsterdam The Netherlands

9. Novartis Pharma AG Basel Switzerland

10. Novartis East Hanover New Jersey

11. Rheumazentrum Ruhrgebiet, Herne, Germany, and Ruhr‐University Bochum Bochum Germany